Find Reports

Select Report Type

Learn More about Reports

Reimbursement Review

Displaying 1251 - 1258 of 1258

Health Technology Review

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 576 - 589 of 589

Horizon Scan

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 101 - 111 of 111

Projects in Progress

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 26 - 40 of 40

View All Reports

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 1726 - 1750 of 2093

Please scroll or swipe to the right to view the full content.

Title	Files	Last Updated Sort ascending	Project Line	Status	Project Number
Icatibant	cdr_SR0375_Firazyr.pdf cdr_complete_SR0375_Firazyr_Dec-23-14.pdf SR0375_Firazyr_CL_Report.pdf SR0375_Firazyr_PE_Report.pdf	Mar 4, 2014	Reimbursement Review	Complete	SR0375-000
Ranibizumab	cdr_SR0373_Lucentis.pdf cdr_complete_SR0373_Lucentis_CNV_Feb-20-15.pdf SR0373_LucentisCNV_CL_Report_e.pdf SR0373_LucentisCNV_PE_Report_e.pdf SR0373_Lucentis_PI_Submissions_e.pdf	Feb 28, 2014	Reimbursement Review	Complete	SR0373-000
Pasireotide diaspartate	cdr_SR0372_Signifor.pdf cdr_complete_SR0372_Signifor_Feb-26-15.pdf SR0372_Signifor_CL_Report.pdf SR0372_Signifor_PE_Report.pdf SR0372 Signifor_PI_Submissions.pdf	Feb 27, 2014	Reimbursement Review	Complete	SR0372-000
Umeclidinium/vilanterol	cdr_SR0371_Anoro_Ellipta.pdf cdr_complete_SR0371_Anoro_Ellipta_Jan-23-15.pdf SR0371_Anoro_Ellipta_PI_Submissions.pdf SR0371_Anoro_Ellipta_CL_Report_e.pdf SR0371_Anoro_Ellipta_PE_Report_e.pdf	Feb 26, 2014	Reimbursement Review	Complete	SR0371-000
Trisenox for Acute Promyelocytic Leukemia - Details	pcodr-provfund_trisenox-apl.pdf pcodr-trisenox-apl-fn-rec.pdf pcodr-trisenox-apl-fn-cgr.pdf pcodr-trisenox-apl-fn-egr.pdf pcodr-trisenox-apl-in-rec.pdf pcodr-trisenox-apl-pag-fdbdk.pdf pcodr-trisenox-apl-coi-llsc.pdf	Feb 18, 2014	Reimbursement Review	Complete	PC0033-000
Indacaterol/glycopyrronium	cdr_SR0369_Ultibro_Breezhaler.pdf cdr_complete_SR0369_Ultibro Breezhaler_Jan30_2015.pdf SR0369_Ultibro Breezhaler_PI.pdf SR0369_UltibroBreezhaler_CL_Report.pdf SR0369_UltibroBreezhaler_PE_Report.pdf	Feb 3, 2014	Reimbursement Review	Complete	SR0369-000
Alogliptin	cdr_SR0368_Nesina.pdf cdr_complete_SR0368_Nesina_Jan-19-15.pdf SR0368_Nesina_CL_Report.pdf SR0368_Nesina_PE_Report.pdf SR0368_Nesina_PI_Submissions.pdf	Jan 30, 2014	Reimbursement Review	Complete	SR0368-000
Alogliptin Plus Metformin	cdr_SR0367_Kazano.pdf cdr_complete_SR0367_Kazano_Jan-19-15.pdf SR0367_Kazano_PE_Report.pdf SR0367_Kazano_CL_Report.pdf SR0367_Kazano_PI_Submissions.pdf	Jan 30, 2014	Reimbursement Review	Complete	SR0367-000
Erbitux for Metastatic Colorectal Cancer - Details	pcodr-provfund_erbitux-mcrc.pdf pcodr-erbitux-mcrc-fn-rec.pdf pcodr-erbitux-mcrc-fn-cgr.pdf pcodr-erbitux-mcrc-fn-egr.pdf pcodr-erbitux-mcrc-in-rec.pdf pcodr-erbitux-mcrc-pagfdk.pdf pcodr-erbitux-mcrc-fdbk-ccac.pdf pcodr-erbitux-mcrc-coi-ccac.pdf	Jan 27, 2014	Reimbursement Review	Complete	PC0031-000
Vismodegib (Erivedge) for Advanced BCC - Details	pcodr-provfund_erivedge-abcc.pdf pcodr-erivedge-bcc-fn-rec.pdf pcodr-erivedge-bcc-fn-cgr.pdf pcodr-erivedge-bcc-fn-egr.pdf pcodr-erivedge-bcc-in-rec.pdf pcodr-erivedge-bcc-pagfdk.pdf pcodr-erivedge-bcc-fdk-roche.pdf pcodr-erivedge-bcc-fdk-sys.pdf pcodr-erivedge-bcc-coi-sys.pdf pcodr-erivedge-bcc-coi-mnc.pdf	Jan 27, 2014	Reimbursement Review	Complete	PC0015-000
Trastuzumab emtansine for Metastatic Breast Cancer - Details	pcodr-provfund_kadcyla-mbc.pdf pcodr-kadcyla-mbc-fn-rec.pdf pcodr-kadcyla-mbc-fn-cgr.pdf pcodr-kadcyla-mbc-fn-egr.pdf pcodr-kadcyla-mbc-in-rec.pdf pcodr-kadcyla-mbc-pagfdk.pdf pcodr-kadcyla-mbc-fdk-roche.pdf pcodr-kadcyla-mbc-coi-cbcn.pdf pcodr-kadcyla-mbc-coi-rebc.pdf	Jan 27, 2014	Reimbursement Review	Complete	PC0024-000
Aripiprazole	cdr_SR0366_Abilify_Maintena.pdf SR0366_Abilify Maintena_CL_Report.pdf SR0366_Abilify Maintena_PE_Report.pdf SR0366_Abilify Maintena_PI_Submissions.pdf cdr_complete_SR0366_Abilify-Maintena_Dec-23-14.pdf	Jan 6, 2014	Reimbursement Review	Complete	SR0366-000
Adalimumab	cdr_SR0365_Humira.pdf	Dec 23, 2013	Reimbursement Review	Withdrawn	SR0365-000
Adcetris for systemic Anaplastic Large Cell Lymphoma - Details	pcodr-provfund_adcetris-salcl.pdf pcodr-adcetris-salcl-fn-rec.pdf pcodr-adcetris-salcl-fn-cgr.pdf pcodr-adcetris-salcl-fn-egr.pdf pcodr-adcetris-salcl-in-rec.pdf pcodr-adcetris-salcl-pagfdk.pdf pcodr-adcetris-salcl-coi-lfc.pdf	Dec 20, 2013	Reimbursement Review	Complete	PC0021-000
Tafinlar for Metastatic Melanoma - Details	pcodr-provfund_tafinlar-metmel.pdf pcodr-tafinlar-metmla-fn-rec.pdf pcodr-tafinlar-metmla-fn-cgr.pdf pcodr-tafinlar-metmla-fn-egr.pdf pcodr-tafinlar-metmla-in-rec.pdf pcodr-tafinlar-pag-fdk-in-rec.pdf pcodr-tafinlar-in-fdk-gsk.pdf pcodr-tafinlar-ptfdk-mnc.pdf pcodr-tafinlar-coi-mnc.pdf pcodr-tafinlar-ptfdk-sysf.pdf pcodr-tafinlar-coi-sysf.pdf	Dec 20, 2013	Reimbursement Review	Complete	PC0025-000
Macitentan	cdr_SR0364_Opsumit.pdf cdr_complete_SR0364_Opsumit_Jan-30-15.pdf SR0364_Opsumit_CL_Report_e.pdf SR0364_Opsumit_PE_Report_e.pdf SR0364_Opsumit_PI_e.pdf	Dec 18, 2013	Reimbursement Review	Complete	SR0364-000
Pemetrexed Alimta for Advanced Non-Squamous Non-Small Cell Lung Cancer (NS-NSCLC) - Details	pcodr_provfund_alimta-nsclc.pdf pcodr-alimta-ns-nsclc-fn-rec.pdf pcodr-alimta-ns-nsclc-fn-cgr.pdf pcodr-alimta-ns-nsclc-fn-egr.pdf pcodr-alimta-ns-nsclc-in-rec.pdf pcodr-alimta-pagfdk-inrec.pdf pcodr-alimta-infdk-elilc.pdf pcodr-alimta-coi-ccsn.pdf pcodr-alimta-coi-lcc.pdf	Dec 5, 2013	Reimbursement Review	Complete	PC0027-000
Stivarga for Metastatic Colorectal Cancer - Details	pcodr_provfund_stivarga-mcrc.pdf pcodr-stivargamcrc-fn-rec.pdf pcodr-stivargamcrc-fn-cgr.pdf pcodr-stivargamcrc-fn-egr.pdf pcodr-stivargamcrc-in-rec.pdf pcodr-stivarga-mcrc-pagfdk-inr.pdf pcodr-stivarga-mcrc-fdk-bayer.pdf pcodr-stivarga-mcrc-ptfdk-ccac.pdf pcodr-stivarga-mcrc-coi-ccac.pdf	Dec 2, 2013	Reimbursement Review	Complete	PC0026-000
Mirabegron	cdr_SR0363_Myrbetriq.pdf cdr_complete_SR0363_Myrbetriq_nov14_2014.pdf SR0363_Myrbetriq_CL_Report_e.pdf SR0363_Myrbetriq_PE_Report_e.pdf SR0363_Myrbetriq_PI_Submissions_e.pdf	Nov 27, 2013	Reimbursement Review	Complete	SR0363-000
OnabotulinumtoxinA	cdr_SR0362_Botox_OAB.pdf cdr_complete_SR0362_Botox-OAB_nov14_2014.pdf SR0362_BotoxOAB_CL_Report_e.pdf SR0362_BotoxOAB_PE_Report_e.pdf SR0362_Botox OAB_PI_Submissions_e.pdf	Nov 25, 2013	Reimbursement Review	Complete	SR0362-000
Aflibercept	cdr_SR0361_Eylea.pdf cdr_complete_SR0361-000_eylea_october_22_2014.pdf SR0361_Eylea_CL_Report.pdf SR0361_Eylea_PE_Report.pdf SR0361_Eylea_PI_Submissions.pdf	Nov 18, 2013	Reimbursement Review	Complete	SR0361-000
Mekinist for Metastatic Melanoma - Details	pcodr_provfund_mekinist-metmel.pdf pcodr-mekinist-mm-fn-rec.pdf pcodr-mekinist-metmela-fn-cgr.pdf pcodr-mekinist-metmela-fn-egr.pdf pcodr-mekinist-metmela-in-rec.pdf pcodr-mekinist-pag-fdk-in-rec.pdf pcodr-mekinist-in-fdk-gsk.pdf pcodr-mekinist-in-fdk-mnc.pdf pcodr-mekinist-coi-mnc.pdf	Nov 6, 2013	Reimbursement Review	Complete	PC0030-000
Revlimid for Multiple Myeloma - Details	pcodr_provfund_revlimid-mm.pdf pcodr-revlimid-mm-fn-rec.pdf pcodr-revlimid-mm-fn-cgr.pdf pcodr-revlimid-mm-fn-egr.pdf pcodr-revlimid-mm-in-rec.pdf pcodr-revlimid-pag-fdk-in-rec.pdf pcodr-revlimid-in-fdk-celgene.pdf pcodr-revlimid-coi-mc.pdf	Nov 6, 2013	Reimbursement Review	Complete	PC0029-000
Zytiga for Metastatic Castration Resistant Prostate Cancer - Details	pcodr_profund_abiraterone_zytiga_mcrpc.pdf pcodr-zytiga-mcrpc-fn-rec.pdf pcodr-zytiga-mcrpc-fn-cgr.pdf pcodr-zytiga-mcrpc-fn-egr.pdf pcodr-zytiga-mcrpc-in-rec.pdf pcodr-zytiga-pag-fdk-in-rec.pdf pcodr-zytiga-in-fdk-janssen.pdf pcodr-zytiga-in-fdk-ccsn.pdf pcodr-zytiga-coi-ccsn.pdf pcodr-zytiga-in-fdk-pcc.pdf pcodr-zytiga-coi-pcc.pdf	Nov 6, 2013	Reimbursement Review	Complete	PC0028-000
Stiripentol	cdr_SR0360_Diacomit.pdf cdr_complete_SR0360_Diacomit_October_20_2014.pdf sr0360_diacomit_cl_report.pdf sr0360_diacomit_pe_report.pdf	Oct 30, 2013	Reimbursement Review	Complete	SR0360-000